Perceptive Advisors LLC
- SEC CIK
- 0001224962
- Latest filing
- Aug 14, 2026
Holdings in Q4 2023
Holdings as of Dec 31, 2023, filed Feb 26, 2024. Long positions only; changes compare share counts with Q3 2023.
- Positions
- 97
- +10 vs. Q3 2023
- Portfolio value
- $4.47B
- +$1.50B (+50.4%) vs. Q3 2023
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| CERECerevel Therapeutics Holdings, Inc. | COM | 10,965,193 | $464.9M | 10.4% | +876,808+8.7% | Added | History |
| FOLDAmicus Therapeutics, Inc. | COM | 28,057,456 | $398.1M | 8.9% | +364,539+1.3% | Added | History |
| LIANYLianBio | SPONSORED ADS | 57,558,451 | $257.3M | 5.8% | 00.0% | Unchanged | History |
| ACLXArcellx, Inc. | COMMON STOCK | 4,544,809 | $252.2M | 5.6% | +578,831+14.6% | Added | History |
| NUVLNuvalent, Inc. | COM | 2,917,991 | $214.7M | 4.8% | +454,540+18.5% | Added | History |
| INBXInhibrx Biosciences, Inc. | COM | 4,256,104 | $161.7M | 3.6% | 00.0% | Unchanged | History |
| SLNOSoleno Therapeutics Inc | COM | 3,074,542 | $123.8M | 2.8% | 00.0% | Unchanged | History |
| RYTMRhythm Pharmaceuticals, Inc. | COM | 2,154,110 | $99.0M | 2.2% | +1,773,282+465.6% | Added | History |
| IMVTImmunovant, Inc. | COM | 2,328,082 | $98.1M | 2.2% | −1,486,609−39.0% | Reduced | History |
| IOVAIovance Biotherapeutics, Inc. | COM | 11,979,415 | $97.4M | 2.2% | +16,477+0.1% | Added | History |
| CBAYCymaBay Therapeutics, Inc. | COM | 4,024,400 | $95.1M | 2.1% | −18,791−0.5% | Reduced | History |
| AXSMAxsome Therapeutics, Inc. | COM | 1,038,019 | $82.6M | 1.8% | +556,370+115.5% | Added | History |
| MDTMedtronic plc | Stock | 976,652 | $80.5M | 1.8% | +389,652+66.4% | Added | History |
| CRGXCARGO Therapeutics, Inc. | COM | 3,436,600 | $79.6M | 1.8% | +3,436,600 | New | History |
| MGTXMeiraGTx Holdings plc | COM | 11,331,103 | $79.5M | 1.8% | 00.0% | Unchanged | History |
| VRNAVerona Pharma plc | SPONSORED ADS | 3,866,214 | $76.9M | 1.7% | −140,983−3.5% | Reduced | History |
| BHVNBiohaven Ltd. | COM | 1,725,047 | $73.8M | 1.7% | +973,227+129.4% | Added | History |
| SWTXSpringWorks Therapeutics, Inc. | COM | 1,957,246 | $71.4M | 1.6% | +436,830+28.7% | Added | History |
| BBIOBridgeBio Pharma, Inc. | COM | 1,748,933 | $70.6M | 1.6% | 00.0% | Unchanged | History |
| PCVXVaxcyte, Inc. | COM | 1,088,486 | $68.4M | 1.5% | −254,265−18.9% | Reduced | History |
| LYRALyra Therapeutics, Inc. | COM | 12,757,562 | $66.8M | 1.5% | 00.0% | Unchanged | History |
| IRONDisc Medicine, Inc. | COM | 1,023,045 | $59.1M | 1.3% | +127,404+14.2% | Added | History |
| SYRESpyre Therapeutics, Inc. | COM NEW | 2,606,679 | $56.1M | 1.3% | +2,525,563+3,113.5% | Added | History |
| NTRANatera, Inc. | COM | 850,225 | $53.3M | 1.2% | +632,047+289.7% | Added | History |
| RAPTRAPT Therapeutics, Inc. | COM | 2,139,950 | $53.2M | 1.2% | +219,292+11.4% | Added | History |
| VRCAVerrica Pharmaceuticals Inc. | COM | 7,099,182 | $52.0M | 1.2% | +2,060,199+40.9% | Added | History |
| RCKTRocket Pharmaceuticals, Inc. | COM | 1,707,398 | $51.2M | 1.1% | +189,931+12.5% | Added | History |
| APGEApogee Therapeutics, Inc. | COM | 1,827,901 | $51.1M | 1.1% | 00.0% | Unchanged | History |
| XENEXenon Pharmaceuticals Inc. | COM | 1,100,748 | $50.7M | 1.1% | +483,248+78.3% | Added | History |
| RYZBRayzeBio, Inc. | COM | 744,056 | $46.3M | 1.0% | −32,749−4.2% | Reduced | History |
| CABACabaletta Bio, Inc. | COM | 2,003,058 | $45.5M | 1.0% | +870,567+76.9% | Added | History |
| CRNXCrinetics Pharmaceuticals, Inc. | COM | 1,255,512 | $44.7M | 1.0% | −8,220−0.7% | Reduced | History |
| SRPTSarepta Therapeutics, Inc. | COM | 451,873 | $43.6M | 1.0% | +269,153+147.3% | Added | History |
| EOLSEvolus, Inc. | COM | 3,963,424 | $41.7M | 0.9% | +2,477,623+166.8% | Added | History |
| VRDNViridian Therapeutics, Inc. | COM | 1,730,212 | $37.7M | 0.8% | +719,007+71.1% | Added | History |
| NAUTNautilus Biotechnology, Inc. | COM | 12,594,211 | $37.7M | 0.8% | +3,483,060+38.2% | Added | History |
| ABBVAbbVie Inc. | Stock | 238,000 | $36.9M | 0.8% | +238,000 | New | History |
| IMTXImmatics N.V. | SHS | 3,491,500 | $36.8M | 0.8% | 00.0% | Unchanged | History |
| NBIXNeurocrine Biosciences Inc | Stock | 270,794 | $35.7M | 0.8% | +111,552+70.1% | Added | History |
| MDGLMadrigal Pharmaceuticals, Inc. | COM | 151,151 | $35.0M | 0.8% | +26,514+21.3% | Added | History |
| ATXSAstria Therapeutics, Inc. | COM | 4,004,070 | $30.8M | 0.7% | +1,814,608+82.9% | Added | History |
| ALDXAldeyra Therapeutics, Inc. | COM | 8,593,586 | $30.2M | 0.7% | −2,756,499−24.3% | Reduced | History |
| ADMAAdma Biologics, Inc. | COM | 6,433,369 | $29.1M | 0.7% | −550,950−7.9% | Reduced | History |
| AMLXAmylyx Pharmaceuticals, Inc. | COM | 1,869,125 | $27.5M | 0.6% | −819,748−30.5% | Reduced | History |
| FUSNFusion Pharmaceuticals Inc. | COM | 2,751,395 | $26.4M | 0.6% | 00.0% | Unchanged | History |
| TARSTarsus Pharmaceuticals, Inc. | COM | 1,296,416 | $26.3M | 0.6% | 00.0% | Unchanged | History |
| RVMDRevolution Medicines, Inc. | COM | 818,882 | $23.5M | 0.5% | −502,913−38.0% | Reduced | History |
| AKROAkero Therapeutics, Inc. | COM | 967,775 | $22.6M | 0.5% | −651,650−40.2% | Reduced | History |
| OBIOOrchestra BioMed Holdings, Inc. | COM | 2,432,089 | $22.2M | 0.5% | 00.0% | Unchanged | History |
| CELCCelcuity Inc. | COM | 1,481,300 | $21.6M | 0.5% | +1,481,300 | New | History |
| SLDBSolid Biosciences Inc. | COM NEW | 3,495,933 | $21.5M | 0.5% | 00.0% | Unchanged | History |
| ISRGIntuitive Surgical Inc | COM NEW | 55,000 | $18.6M | 0.4% | +55,000 | New | History |
| AORTArtivion, Inc. | COM | 931,352 | $16.7M | 0.4% | 00.0% | Unchanged | History |
| ASNDAscendis Pharma A/S | SPONSORED ADR | 132,176 | $16.6M | 0.4% | +132,176 | New | History |
| TMCITreace Medical Concepts, Inc. | COM | 1,250,405 | $15.9M | 0.4% | −583,655−31.8% | Reduced | History |
| MIRMMirum Pharmaceuticals, Inc. | COM | 534,942 | $15.8M | 0.4% | −137,100−20.4% | Reduced | History |
| ACRVAcrivon Therapeutics, Inc. | COMMON STOCK | 3,007,858 | $14.8M | 0.3% | 00.0% | Unchanged | History |
| ARVNArvinas, Inc. | COM | 354,082 | $14.6M | 0.3% | +354,082 | New | History |
| APLTApplied Therapeutics, Inc. | COM | 4,080,249 | $13.7M | 0.3% | +4,080,249 | New | History |
| EYPTEyePoint, Inc. | COM NEW | 589,646 | $13.6M | 0.3% | +589,646 | New | History |
| LONALeonaBio, Inc. | COM | 5,402,964 | $13.1M | 0.3% | +605,686+12.6% | Added | History |
| AUTLAutolus Therapeutics plc | SPON ADS | 1,831,167 | $11.8M | 0.3% | +1,831,167 | New | History |
| ZYMEZymeworks Inc. | COM | 1,074,807 | $11.2M | 0.2% | −371,316−25.7% | Reduced | History |
| TNGXTango Therapeutics, Inc. | COM | 1,111,870 | $11.0M | 0.2% | −1,307,098−54.0% | Reduced | History |
| TCMDTactile Systems Technology Inc | COM | 707,159 | $10.1M | 0.2% | 00.0% | Unchanged | History |
| PTGXProtagonist Therapeutics, Inc | COM | 383,260 | $8.79M | 0.2% | −671,013−63.6% | Reduced | History |
| ITCIIntra-Cellular Therapies, Inc. | COM | 108,000 | $7.73M | 0.2% | +108,000 | New | History |
| OLMAOlema Pharmaceuticals, Inc. | COM | 539,831 | $7.57M | 0.2% | +539,831 | New | History |
| TERNTerns Pharmaceuticals, Inc. | COM | 1,075,000 | $6.98M | 0.2% | 00.0% | Unchanged | History |
| COGTCogent Biosciences, Inc. | COM | 1,122,958 | $6.60M | 0.1% | −1,186,512−51.4% | Reduced | History |
| RGNXREGENXBIO Inc. | COM | 342,408 | $6.15M | 0.1% | +342,408 | New | History |
| EWTXEdgewise Therapeutics, Inc. | COM | 555,555 | $6.08M | 0.1% | +555,555 | New | History |
| MGNXMacrogenics Inc | COM | 611,932 | $5.89M | 0.1% | +611,932 | New | History |
| AXGNAxogen, Inc. | COM | 808,380 | $5.52M | 0.1% | −67,518−7.7% | Reduced | History |
| LABPLandos Biopharma, Inc. | COM NEW | 1,486,991 | $5.44M | 0.1% | 00.0% | Unchanged | History |
| TYRATyra Biosciences, Inc. | COM | 360,000 | $4.99M | 0.1% | 00.0% | Unchanged | History |
| MLTXMoonLake Immunotherapeutics | CLASS A ORD | 82,398 | $4.98M | 0.1% | +82,398 | New | History |
| NBTXNanobiotix S.A. | SPONSORED ADS | 555,066 | $4.04M | 0.1% | 00.0% | Unchanged | History |
| VERUVeru Inc. | COM | 5,584,699 | $4.02M | 0.1% | +4,494,821+412.4% | Added | History |
| TVTXTravere Therapeutics, Inc. | COM | 400,000 | $3.60M | 0.1% | 00.0% | Unchanged | History |
| NVNOenVVeno Medical Corp | COMMON STOCK | 623,315 | $3.20M | 0.1% | −158,300−20.3% | Reduced | History |
| ACADAcadia Pharmaceuticals Inc | COM | 101,000 | $3.16M | 0.1% | +101,000 | New | History |
| XFORX4 Pharmaceuticals, Inc | COM | 3,545,454 | $2.97M | 0.1% | 00.0% | Unchanged | History |
| FBRXForte Biosciences, Inc. | COM | 3,265,359 | $2.68M | 0.1% | 00.0% | Unchanged | History |
| CYTKCytokinetics Inc | COM NEW | 30,317 | $2.53M | 0.1% | +30,317 | New | History |
| KRONKronos Bio, Inc. | COM | 1,752,745 | $2.19M | <0.1% | 00.0% | Unchanged | History |
| ESTAEstablishment Labs Holdings Inc. | COM | 82,299 | $2.13M | <0.1% | −195,384−70.4% | Reduced | History |
| CMAXCareMax, Inc. | COM CL A | 3,679,284 | $1.83M | <0.1% | −144,273−3.8% | Reduced | History |
| MORFMorphic Holding, Inc. | COM | 56,980 | $1.65M | <0.1% | +56,980 | New | History |
| AMAMAmbrx Biopharma, Inc. | COM | 78,811 | $1.12M | <0.1% | +78,811 | New | History |
| OMICSingular Genomics Systems, Inc. | COM | 2,126,893 | $978.6K | <0.1% | −236,321−10.0% | Reduced | History |
| VBIVVBI Vaccines Inc/BC | COM | 1,381,355 | $815.0K | <0.1% | 00.0% | Unchanged | History |
| CYPHCypherpunk Technologies Inc. | COM NEW | 44,971 | $186.4K | <0.1% | 00.0% | Unchanged | History |
| BCABBioAtla, Inc. | COM | 73,000 | $179.6K | <0.1% | +73,000 | New | History |
| RVMDWRevolution Medicines, Inc. | *W EXP 12/17/202 | 250,000 | $82.5K | <0.1% | +250,000 | New | History |
| Surrozen, Inc.86889P117 | *W EXP 08/01/203 | 166,666 | $3.33K | <0.1% | 00.0% | Unchanged | – |
| CareMax, Inc.14171W111 | *W EXP 06/08/202 | 60,000 | $450 | <0.1% | 00.0% | Unchanged | – |
Options (4)
Puts and calls in the same filing. Amounts are the market value of the underlying shares, which is what 13F reports.
Sold out since Q3 2023 (11)
Positions held at the end of Q3 2023 that are gone from this filing.
| Security | Class | Shares in Q3 2023 | Value in Q3 2023 | % of portfolio in Q3 2023 | History |
|---|---|---|---|---|---|
| ARGXArgenx SE | SPONSORED ADR | 150,600 | $74.0M | 2.5% | History |
| ROIVRoivant Sciences Ltd. | SHS | 3,819,456 | $44.6M | 1.5% | History |
| HRMYHarmony Biosciences Holdings, Inc. | COM | 996,306 | $32.6M | 1.1% | History |
| RLAYRelay Therapeutics, Inc. | COM | 1,943,097 | $16.3M | 0.5% | History |
| BMEABiomea Fusion, Inc. | COM | 716,441 | $9.86M | 0.3% | History |
| PRTAProthena Corp Public Ltd Co | SHS | 165,615 | $7.99M | 0.3% | History |
| OMOutset Medical, Inc. | COM | 661,977 | $7.20M | 0.2% | History |
| SLGCSomaLogic, Inc. | CLASS A COM | 1,500,000 | $3.58M | 0.1% | History |
| SLRNACELYRIN, Inc. | COM | 200,000 | $2.03M | 0.1% | History |
| MOTSMotus GI Holdings, Inc. | COM NEW | 90,027 | $40.5K | <0.1% | History |
| EQRx, Inc.26886C115 | *W EXP 12/17/202 | 250,000 | $10.0K | <0.1% | – |